Twist Bioscience Corp SEC filings TWST
Twist Bioscience Corp has 1,007 filings in SEC EDGAR's recent list, going back to Oct 4, 2022. Its latest annual report, Form ARS, was filed on Jan 6, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jan 6, 2026 | Feb 5, 2026 |
| DEF 14A | Proxy statement | Jan 6, 2025 | Jan 6, 2025 |
| PRE 14A | Preliminary proxy statement | Dec 26, 2024 | Dec 26, 2024 |
| DEF 14A | Proxy statement | Jan 5, 2024 | Feb 6, 2024 |
| DEF 14A | Proxy statement | Jan 6, 2023 | Feb 7, 2023 |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TWST (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1581280
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.